Skip to main content

Volume 21 - Issue 7 - July 2013

Featured Article

Cover Story
07/22/2013
Cosmeceuticals have the potential to benefit a multitude of patients. Utilizing the science behind the products will enable the dermatology provider to offer all patients a cosmeceutical regimen that is tailored to individual...
Cosmeceuticals have the potential to benefit a multitude of patients. Utilizing the science behind the products will enable the dermatology provider to offer all patients a cosmeceutical regimen that is tailored to individual...
Cosmeceuticals have the...
07/22/2013
The Dermatologist
04/07/2016
Dermatologists may start to reconsider biologics as a viable option in the treatment of pediatric psoriasis. However, at this time, most data concerning the outcomes and side effects of biologics have been garnered from studies involving an...
Dermatologists may start to reconsider biologics as a viable option in the treatment of pediatric psoriasis. However, at this time, most data concerning the outcomes and side effects of biologics have been garnered from studies involving an...
Dermatologists may start to...
04/07/2016
The Dermatologist
04/07/2016
In an analysis using MarketScan Commercial Database to determine the costs of biologic treatment in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriasis and ankylosing spondylitis (AS), Machaon M. Bonafede, PhD, and...
In an analysis using MarketScan Commercial Database to determine the costs of biologic treatment in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriasis and ankylosing spondylitis (AS), Machaon M. Bonafede, PhD, and...
In an analysis using MarketScan...
04/07/2016
The Dermatologist
04/07/2016
A longitudinal study conducted in Sweden by David Hägg, a doctoral student at Umea University, and colleagues sought to understand whether the lower percentage of female psoriasis patients treated with biologics is related to gender...
A longitudinal study conducted in Sweden by David Hägg, a doctoral student at Umea University, and colleagues sought to understand whether the lower percentage of female psoriasis patients treated with biologics is related to gender...
A longitudinal study conducted...
04/07/2016
The Dermatologist
04/07/2016
A recent study conducted by Kantar Health discovered 4 in 10 individuals with psoriasis do not consult a doctor for their condition. The self-administered survey, called the Psoriasis Syndicated Patient Study, also revealed that, out of those...
A recent study conducted by Kantar Health discovered 4 in 10 individuals with psoriasis do not consult a doctor for their condition. The self-administered survey, called the Psoriasis Syndicated Patient Study, also revealed that, out of those...
A recent study conducted by...
04/07/2016
The Dermatologist
04/07/2016
As the new managing editor of The Dermatologist, it is my pleasure to welcome you to read this special issue on biologics, an area with great signifcance to dermatologists and their patients. A recent study by IMS Health showed that biologics...
As the new managing editor of The Dermatologist, it is my pleasure to welcome you to read this special issue on biologics, an area with great signifcance to dermatologists and their patients. A recent study by IMS Health showed that biologics...
As the new managing editor of...
04/07/2016
The Dermatologist
07/22/2013
One physician offers a plea for compassionate and comprehensive patient care.
One physician offers a plea for compassionate and comprehensive patient care.
One physician offers a plea for...
07/22/2013
The Dermatologist
07/22/2013
Chromoblastomycosis, or chromomycosis, is a subcutaneous, dematiaceous fungal infection, resulting from skin inoculation by pigmented fungi including Fonsecaea pedrosoi, Phialophora verrucosa, Cladophialophora carrionii, Fonsecaea...
Chromoblastomycosis, or chromomycosis, is a subcutaneous, dematiaceous fungal infection, resulting from skin inoculation by pigmented fungi including Fonsecaea pedrosoi, Phialophora verrucosa, Cladophialophora carrionii, Fonsecaea...
Chromoblastomycosis, or...
07/22/2013
The Dermatologist

Column

Spotlight
07/22/2013
Dr. Macrene Alexiades-Armenakas received her three degrees from Harvard University: a BA from Harvard University, an MD from Harvard Medical School and a PhD in Genetics from Harvard University. 
Dr. Macrene Alexiades-Armenakas received her three degrees from Harvard University: a BA from Harvard University, an MD from Harvard Medical School and a PhD in Genetics from Harvard University. 
Dr. Macrene Alexiades-Armenakas...
07/22/2013
The Dermatologist
Legal Ease
07/22/2013
Litigation filed against two physicians highlight an expanding list of reasons why doctors may face lawsuits.
Litigation filed against two physicians highlight an expanding list of reasons why doctors may face lawsuits.
Litigation filed against two...
07/22/2013
The Dermatologist

Department

Cosmetic Clinic
07/22/2013
The search for a “fountain of youth” and increasing media attention often prompt patients to inquire about hormones and other supplements.   
The search for a “fountain of youth” and increasing media attention often prompt patients to inquire about hormones and other supplements.   
The search for a “fountain of...
07/22/2013
The Dermatologist